Arax Advisory Partners’s Counterpoint Quantitative Equity ETF CPAI Stock Holding History
Bought
Maintained
Sold
Other funds holding CPAI
Arax Advisory Partners's CPAI Position: Q3 2026 in Review
Arax Advisory Partners reduced its Counterpoint Quantitative Equity ETF (CPAI) stake by 1.3% in Q3 2026, selling an estimated $277K and leaving 421,050 shares worth $21.8M. The position accounts for 0.12% of the portfolio, ranked #180.
Arax Advisory Partners first reported a position in CPAI in Q2 2026 and has held it in 2 quarters since. The position peaked at $22.2M in Q2 2026. 54 funds tracked by Wall St. Rank hold CPAI as of Q3 2026.
- Arax Advisory Partners held 421,050 shares of Counterpoint Quantitative Equity ETF worth $21.8M as of Q3 2026.
- Arax Advisory Partners sold 5,375 Counterpoint Quantitative Equity ETF shares in Q3 2026, an estimated $277K.
- Counterpoint Quantitative Equity ETF made up 0.12% of Arax Advisory Partners's portfolio in Q3 2026, its #180 holding.
- Arax Advisory Partners first reported a position in Counterpoint Quantitative Equity ETF in Q2 2026 and has held it in 2 quarters since.
- Arax Advisory Partners's Counterpoint Quantitative Equity ETF position peaked at $22.2M in Q2 2026.
- 54 funds tracked by Wall St. Rank held Counterpoint Quantitative Equity ETF as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.